Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Total Assignments:
1
|
|
Patent #:
|
|
Issue Dt:
|
04/18/2017
|
Application #:
|
14440001
|
Filing Dt:
|
04/30/2015
|
|
Publication #:
|
|
Pub Dt:
|
09/24/2015
| | | | |
|
Inventors:
|
Stéphane Prost, Mikael Le Dantec, Philippe Rousselot, Marek Kirszenbaum et al
|
|
Title:
|
COMBINATION OF AN ANTI-CANCER AGENT SUCH AS A TYROSINEKINASE INHIBITOR AND A STAT5 ANTAGONIST, PREFERABLY A THIAZOLIDINEDIONE, FOR ELIMINATING HEMATOLOGIC CANCER STEM CELLS IN VIVO AND FOR PREVENTING HEMATOLOGIC CANCER RELAPSE
|
|
|
Assignment:
1
|
|
|
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
|
|
|
| 25, RUE LEBLANC |
| BATIMENT "LE PONANT" |
| PARIS, FRANCE 75015 |
|
|
|
|
| NELSON MULLINS RILEY & SCARBOROUGH LLP |
| ONE POST OFFICE SQUARE |
| FL 30 |
| BOSTON, MA 02109 |
|
|
Search Results as of:
06/04/2024 01:13 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
